Through suppressing the activation of PI3K/AKT and NF-κB signaling pathways, the combination of an SHP2 inhibitor and 5-fluorouracil (5-FU) can synergistically induce apoptosis and impede the proliferation of cervical cancer cells (137). Here, PTPN11 is linked to cervical carcinoma.